Aromatase inhibitor: clinical trials recruiting now
3
Recruiting trials
2
Conditions studied
5
US states with sites
6
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer · Aromatase inhibitor for Breast Cancer | 3 |
| Advanced Solid Tumor | 1 |
Recruiting trials involving Aromatase inhibitor
- An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
- Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
- Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Common questions
How many recruiting trials involve Aromatase inhibitor?
3 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.